Overview

Vestibular Versus Sublingual Route of AIT Tablets

Status:
Recruiting

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

Summary

To evaluate the tolerability of the vestibular administration route of birch pollen, grass pollen, ragweed pollen, and house dust mite (HDM) AIT tablets compared with the sublingual route in adult subjects with allergic rhinitis/conjunctivitis (AR/C)

Phase:

Phase 4

Details

Lead Sponsor:

Clinique Spécialisée en Allergies de la Capitale

Collaborator:

ALK-Abelló A/S